• Partial BACE Inhibition Preserves Synaptic Transmission

  2026-09-25

  Satir et al. tested whether reducing amyloid-β (Aβ) production with β-secretase inhibitors necessarily disrupts neuronal communication. In cultured rat cortical neurons, Aβ secretion could be reduced by less than 50% without a detectable decrease in synaptic transmission, whereas stronger inhibition was associated with reduced transmission—supporting a dose-sensitive, rather than all-or-none, view of BACE1 inhibition.

• Caspase-3–NDUFS1 Signaling in Trichothecene Liver Injury

  2026-09-25

  A not-yet-peer-reviewed preprint proposes that caspase-3 amplifies trichothecene-induced oxidative stress by cleaving mitochondrial complex I subunit NDUFS1, while ER oxidoreductase ERO1α contributes a second ROS source. The findings connect mitochondrial injury with ER redox stress and suggest experiments that should combine pathway-specific molecular measurements with functional mitochondrial readouts.

• 4-Phenylbutyric Acid: Reading ER Stress Rescue

  2026-09-24

  Discover how 4-Phenylbutyric acid (4-PBA) can help test whether ER stress contributes to cancer-cell death—not merely whether stress markers change. This evidence-led guide translates a liver-cancer study into practical assay design, interpretation, and controls for autophagic cell death research.

• U-73122 in Cancer Invasion: Interpreting PLC Evidence

  2026-09-24

  Learn how U-73122 can test phospholipase C involvement in breast cancer cell invasion without overstating what inhibitor data prove. This guide connects the QPRT study to practical assay design, pathway readouts, and reagent handling.

• Nebivolol Hydrochloride as a TOR Assay Control

  2026-09-23

  Nebivolol hydrochloride is a selective β1-adrenoceptor antagonist, but a 2025 drug-sensitized yeast study found no evidence that it inhibited TOR in that model. This article explains how to interpret that result, use it as a conditional negative comparator, and keep cardiovascular and TOR assay conclusions distinct.

• DAPI Nuclear Stain Solution: Workflow Guide

  2026-09-23

  DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution K2402 provides a ready-to-use fluorescent DNA binding dye for nuclear visualization and endpoint assessment of membrane integrity. It is most appropriate for fixed or membrane-compromised samples analyzed by fluorescence microscopy or flow cytometry, not routine imaging of intact live cells.

• LY2886721 BACE Inhibitor Workflow Guide

  2026-09-22

  LY2886721 supports controlled BACE1 enzyme inhibition across biochemical, cellular, neuronal, and preclinical Alzheimer’s disease workflows. Its strongest use is not simply maximal amyloid beta reduction, but exposure-response mapping that pairs APP-processing biomarkers with synaptic-function measurements.

• Oridonin, Inflammation, and Esophageal Cancer

  2026-09-22

  Peng et al. investigated whether oridonin suppresses experimental esophageal cancer by modulating the TLR4/NF-κB/NLRP3 inflammasome axis. Their integrated histological, inflammatory, hematological, transcriptional, and protein-level data support an inflammation-centered mechanism, while the murine design leaves important questions about dose, causality, and clinical transferability.

• Lyso-Tracker Red for Live-Cell Lysosome Analysis

  2026-09-21

  Lyso-Tracker Red enables selective visualization of acidic lysosomes in living cells, supporting microscopy, flow cytometry, and nanoparticle-trafficking studies. This guide translates the probe’s mechanism into practical workflows for evaluating dendritic-cell uptake, lysosomal remodeling, and antigen-delivery behavior.

• Mubritinib Reveals OXPHOS Dependence in AML

  2026-09-21

  Baccelli et al. used a chemical screen across sequenced primary AML specimens to show that Mubritinib, also known as TAK 165, acts in AML primarily as a ubiquinone-dependent inhibitor of mitochondrial electron transport chain complex I rather than through clinically meaningful HER2 inhibition. The study connects Mubritinib sensitivity with OXPHOS hyperactivity and a genetically distinct subset of chemotherapy-resistant AML, providing a rationale for metabolism-informed experimental stratification.

• Drug-Sensitized Yeast for mTOR Inhibitor Discovery

  2026-09-20

  A 2025 GeroScience study developed a drug-sensitized Saccharomyces cerevisiae platform that detects TOR/mTOR pathway inhibitors at substantially lower concentrations than a wild-type yeast background. The system identified activity for Torin1, GSK2126458, AZD8055, and aminophylline while finding no evidence of TOR inhibition for several other tested compounds, including nebivolol.

• Cy3-UTP: RNA Labeling, Workflow & Limits

  2026-09-19

  Cy3-UTP is a Cy3-modified uridine triphosphate for fluorescent RNA production by in vitro transcription. The product dossier supports its use in RNA imaging, interaction studies, and detection assays, while also defining storage and handling limits that protect signal quality.

• Separating Growth Inhibition from Cell Death

  2026-09-18

  Hannah R. Schwartz’s dissertation shows that relative viability and fractional viability capture different components of anticancer drug response: proliferative arrest and cell killing. This distinction provides a practical framework for designing better in vitro assays, interpreting time-dependent responses, and avoiding conclusions based on a single composite viability endpoint.

• Duplex ddPCR for Long Self-Amplifying RNA

  2026-09-18

  Casmil, Huang, and Blakney developed a duplex reverse-transcription droplet digital PCR workflow for absolute quantification of long self-amplifying RNA and for estimating transcript integrity. The study shows that assay architecture strongly affects apparent full-length yield and that separate genomic and subgenomic measurements can resolve intracellular replication kinetics more clearly than conventional relative qPCR.

• Partial BACE Inhibition and Synaptic Transmission

  2026-09-17

  Satir et al. tested whether modest β-secretase inhibition can reduce amyloid-β secretion without disrupting neuronal function. Using optical electrophysiology in primary rat cortical cultures, they found that reductions below 50% preserved synaptic transmission, whereas stronger inhibition impaired it, supporting exposure-limited BACE strategies rather than maximal enzyme blockade.

7761 records 1/518 page Next 12345 下5页 Last page